The Straits Times sat down with our CEO, Dr Gideon Ho, to find out how Histoindex Pte Ltd’s Genesis®200 system is breaking new grounds in developing drugs for liver conditions, particularly non-alcoholic steatohepatitis (NASH).
Singapore HQ
Teletech Park
20 Science Park Road, #01-26/27
Singapore 117674
UK Branch
Queen Elizabeth University Hospital,
Imaging Centre of Excellence, L3-18, Langlands Drive, Glasgow G51 4LB,
United Kingdom
China Subsidiary Office
Room 1001, Building 10
No. 188 Binkang Road, Hangzhou
Zhejiang 310051, China
©2024 Histoindex Pte Ltd. All Rights Reserved. All logos and trademarks are the property of HistoIndex or their respective owners.